Literature DB >> 11051129

Does the intracarotid amobarbital procedure predict global amnesia after temporal lobectomy?

C S Kubu1, J P Girvin, R S McLachlan, M Pavol, M C Harnadek.   

Abstract

PURPOSE: The intracarotid amobarbital procedure (IAP) is widely used to help predict who might be at risk for postoperative amnesia after unilateral temporal lobectomy for intractable seizures. We describe the memory outcome in 10 patients who underwent standard temporal lobectomy, including mesial temporal structures, despite failing the memory portion of the IAP after injections both ipsilateral and contralateral to the resected seizure focus.
METHODS: Data for seven of the study subjects were obtained through a retrospective review of patients assessed on a surgical epilepsy unit during a 15-year period who failed the Montreal Neurological Institute IAP memory protocol after both ipsilateral and contralateral injections and subsequently underwent unilateral temporal lobectomy. More recently, we have studied temporal lobectomy patients who failed the Medical College of Georgia memory protocol after both ipsilateral and contralateral injections (n = 3). Preoperative and postoperative memory test scores were compared, and data regarding seizure outcome and self-perception of postoperative memory were collected.
RESULTS: At follow-up, none of the patients presented with a pattern indicative of a global amnesia, and 80% demonstrated >90% improvement in their seizure disorder or were seizure-free.
CONCLUSIONS: These findings indicate that bilateral memory failure on the IAP does not preclude the removal of an epileptogenic temporal lobe or a successful surgical outcome. In addition, the findings raise questions regarding the validity of the IAP and the possibility that memory may be reorganized in patients with a long history of temporal lobe epilepsy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11051129     DOI: 10.1111/j.1528-1157.2000.tb04612.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  8 in total

1.  Use of preoperative functional MRI to predict verbal memory decline after temporal lobe epilepsy surgery.

Authors:  Jeffrey R Binder; David S Sabsevitz; Sara J Swanson; Thomas A Hammeke; Manoj Raghavan; Wade M Mueller
Journal:  Epilepsia       Date:  2008-04-24       Impact factor: 5.864

Review 2.  Comparing the Wada Test and Functional MRI for the Presurgical Evaluation of Memory in Temporal Lobe Epilepsy.

Authors:  Andreu Massot-Tarrús; Kevin White; Seyed M Mirsattari
Journal:  Curr Neurol Neurosci Rep       Date:  2019-05-01       Impact factor: 5.081

Review 3.  Functional MRI is a valid noninvasive alternative to Wada testing.

Authors:  Jeffrey R Binder
Journal:  Epilepsy Behav       Date:  2010-09-17       Impact factor: 2.937

Review 4.  Preoperative prediction of verbal episodic memory outcome using FMRI.

Authors:  Jeffrey R Binder
Journal:  Neurosurg Clin N Am       Date:  2011-04       Impact factor: 2.509

Review 5.  The Impact of Right Temporal Lobe Epilepsy On Nonverbal Memory: Meta-regression of Stimulus- and Task-related Moderators.

Authors:  Adam C Bentvelzen; Roy P C Kessels; Nicholas A Badcock; Greg Savage
Journal:  Neuropsychol Rev       Date:  2021-09-24       Impact factor: 6.940

6.  Temporal lobe volume predicts Wada memory test performance in patients with mesial temporal sclerosis.

Authors:  Kan Ding; Yunhua Gong; Pradeep N Modur; Ramon Diaz-Arrastia; Mark Agostini; Puneet Gupta; Roderick McColl; Ryan Hays; Paul Van Ness
Journal:  Epilepsy Res       Date:  2015-11-28       Impact factor: 3.045

7.  Neuropsychology in temporal lobe epilepsy: influences from cognitive neuroscience and functional neuroimaging.

Authors:  Mary Pat McAndrews; Melanie Cohn
Journal:  Epilepsy Res Treat       Date:  2012-01-30

8.  Electrical Wada for pre-surgical memory testing: a case report.

Authors:  Erik Kaestner; Nigel P Pedersen; Ranling Hu; Armin Vosoughi; Abdulrahman Alwaki; Andres Rodriguez Ruiz; Ekaterina Staikova; Kelsey C Hewitt; Charles Epstein; Carrie R McDonald; Robert E Gross; Daniel L Drane
Journal:  Epileptic Disord       Date:  2022-04-01       Impact factor: 2.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.